← All trials
NCT03065218
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2016
- Primary completion
- Feb 15, 2021
- Completion date
- Feb 15, 2021
- First posted
- Feb 27, 2017
- Last posted
- Jul 26, 2022
- Enrollment
- 4
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Georgetown UniversityLead sponsor
- Georgetown UniversityOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.